Genesis Therapeutics Secures $200 Million Funding for AI-Driven Drug Discovery
Several startups specializing in AI-powered drug discovery have recently secured substantial funding. Causaly, BenchSci, Iktos, TandemAI, and Protai have all closed significant funding rounds this year. Joining this list is Genesis Therapeutics, which recently announced the completion of a $200 million Series B funding round. This round brings the total funding for the Burlingame, California-based …